Carboxymaltose

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1034 publications

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity.

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity.

Journal: Renal failure
Published: March 30, 2026

Comparative Clinical Outcomes of Iron Sucrose and Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia.

Comparative Clinical Outcomes of Iron Sucrose and Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia.

Journal: Hospital pharmacy
Published: February 25, 2026

Leukemoid reaction following ferric carboxymaltose infusion in an elderly patient.

Leukemoid reaction following ferric carboxymaltose infusion in an elderly patient.

Journal: BMJ case reports
Published: January 22, 2026

Stability Assessment of Intravenous Iron-Carbohydrate Complexes in Commercial All-in-One Parenteral Nutrition: Potential for Therapeutic Iron Dose Admixing.

Stability Assessment of Intravenous Iron-Carbohydrate Complexes in Commercial All-in-One Parenteral Nutrition: Potential for Therapeutic Iron Dose Admixing.

Journal: Pharmaceutics
Published: January 20, 2026

Corrigendum to: Single Dose of Intravenous Ferric Carboxymaltose Prevents Anemia for 6 Months among Moderately or Severely Anemic Postpartum Women: A Case Study from India. Curr Dev Nutr. 2021; 5(7): nzab078. doi: 10.1093/cdn/nzab078.

Corrigendum to: Single Dose of Intravenous Ferric Carboxymaltose Prevents Anemia for 6 Months among Moderately or Severely Anemic Postpartum Women: A Case Study from India. Curr Dev Nutr. 2021; 5(7): nzab078. doi: 10.1093/cdn/nzab078.

Journal: Current developments in nutrition
Published: January 19, 2026

Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.

Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.

Journal: medRxiv : the preprint server for health sciences
Published: January 16, 2026

Evaluation of Safety and Efficacy of Ferric Carboxymaltose for the Treatment of Iron Deficiency Anaemia in Pregnancy and Postpartum: A Retrospective Observational Study.

Evaluation of Safety and Efficacy of Ferric Carboxymaltose for the Treatment of Iron Deficiency Anaemia in Pregnancy and Postpartum: A Retrospective Observational Study.

Journal: Cureus
Published: January 03, 2026

Comparative Study between Intravenous Ferric Carboxymaltose versus Iron Sucrose in the Treatment of Iron Deficiency Anemia in Postpartum Patients.

Comparative Study between Intravenous Ferric Carboxymaltose versus Iron Sucrose in the Treatment of Iron Deficiency Anemia in Postpartum Patients.

Journal: Mymensingh medical journal : MMJ
Published: December 31, 2025

The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation.

The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation.

Journal: Healthcare (Basel, Switzerland)
Published: December 28, 2025

Potential Benefit of Intravenous Iron Monotherapy for Grade 2-3 Chemotherapy-Induced Anemia Irrespective of Transferrin Saturation Levels.

Potential Benefit of Intravenous Iron Monotherapy for Grade 2-3 Chemotherapy-Induced Anemia Irrespective of Transferrin Saturation Levels.

Journal: Cureus
Published: December 14, 2025

A prospective study of intravenous iron effectiveness on quality of life and functional outcomes in patients with cancer.

A prospective study of intravenous iron effectiveness on quality of life and functional outcomes in patients with cancer.

Journal: Scientific reports
Published: December 03, 2025

High-Dose Intravenous Ferric Carboxymaltose/Derisomaltose Without ESAs for Cancer-Related Anemia in Japan: A Retrospective Single-Center Cohort Study.

High-Dose Intravenous Ferric Carboxymaltose/Derisomaltose Without ESAs for Cancer-Related Anemia in Japan: A Retrospective Single-Center Cohort Study.

Journal: Cancers
Published: December 03, 2025
Showing 1-12 of 1,034

Last Updated: 04/28/2026